drugset
drugset / Trial / NCT01938547

Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER)

NCT01938547 ↗

Phase 4 Terminated 22 enrolled Chiesi Farmaceutici S.p.A.
NaSingle-groupOpen-labelTreatment

Summary

Evaluate the efficacy, safety, and dosing of clevidipine as an intravenous (IV) infusion for blood pressure (BP) management in paediatric participants in the perioperative setting.

Timeline

Start
2014-03-17
Primary completion
2024-02-20
Completion
2024-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Clevidipine Small molecule — Intravenous

Indications

No indication recorded.